Recombinant Human Erythropoietin Increasing Hemoglobin Level and Reducing Blood Transfusion in Femoral Fracture Patients : A Double-Blinded Randomized Controlled Trial Study

Phase 4

Recruiting

• Conditions: hemoglobin loss in femoral fracture patient; blood transfusion; hemoglobin level

• Registration Number: TCTR20230117005
• Lead Sponsor: Faculty of medicine vajira hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-17
• Study Completion: 2024-05-31
• Last Update Posted: 2024-08-19

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Femoral fracture patients age 15 - 80 years old who underwent surgical intervention

Exclusion Criteria

1. patients with hemoglobin less than 9 g/dL, greater than 16 g/dL, 2.on antiplatelets drugs, 3.known case bone marrow disease etc thalassemia, myelodysplastic syndrome, multiple myeloma 4.Chronic kidney disease, 5.Allergy if EPO, 6.Contraindicated for EPO, 7.Severe traumatic brain injury

Study & Design

• Study Type: Interventional
• Study Design: Not specified